Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Alzheimer'S Research & Therapy|November 23, 2024
Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217Branislav Kovacech, Nicholas C Cullen, Petr Novak, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 27, 2016
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibitionJuliane Schelle, Lisa M Häsler, Jens C Göpfert, et al.
Clinical Chemistry and Laboratory Medicine|June 28, 2018
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurementsUlf Andreasson, Julia Kuhlmann, Josef Pannee, et al.
Molecular Neurobiology|August 24, 2018
Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt-Jakob Disease and SynucleinopathyMatthias Schmitz, Anna Villar-Piqué, Franc Llorens, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 23, 2022
Differential diagnostic performance of a panel of plasma biomarkers for different types of dementiaElisabeth H Thijssen, Inge M W Verberk, Jana Kindermans, et al.
Alzheimer'S Research & Therapy|April 17, 2021
Core Alzheimer's disease cerebrospinal fluid biomarker assays are not affected by aspiration or gravity drip extraction methodsJames D Doecke, Cindy Francois, Christopher J Fowler, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 27, 2021
Cellular Prion Protein Mediates α-Synuclein Uptake, Localization, and Toxicity In Vitro and In VivoTobias Thom, Matthias Schmitz, Anna-Lisa Fischer, et al.
Alzheimer'S Research & Therapy|December 20, 2024
Analytical and clinical performance of eight Simoa® and Lumipulse® assays for automated measurement of plasma p-tau181 and p-tau217Anna L Wojdała, Jeroen Vanbrabant, Sherif Bayoumy, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 25, 2016
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisationJulia Kuhlmann, Ulf Andreasson, Josef Pannee, et al.
Alzheimer'S Research & Therapy|October 12, 2016
Prospective longitudinal course of cognition in older subjects with mild parkinsonian signsStefanie Lerche, Kathrin Brockmann, Andrea Pilotto, et al.
Pageof 6